Cannabis, Gut Health, and the Brain: How They Connect

CB1 Receptor Function: Managing Motility and Sensory Signaling

CB1 receptors are distributed throughout the gastric mucosa and the neuromuscular layers of the intestines. When activated by agonists like Delta-9-THC, these receptors may help regulate digestive activity when it becomes overactive.

Managing Transit Time

In cases of hyper-motility or diarrhea-predominant IBS, the gut may move too quickly. CB1 activation may support a slower intestinal transit by inhibiting the release of acetylcholine, a neurotransmitter associated with triggering muscle contractions in the gut.

Addressing Visceral Hypersensitivity

For some, the gut communicates through pain signals, where the brain interprets normal digestive processes as sharp discomfort. Because CB1 receptors are situated on these neural pathways, their activation may help modulate the transmission of pain signals, potentially offering relief from discomfort.

Gastric Acid Regulation

Cannabinoids interact with the proton pumps lining the stomach. By modulating CB1 signaling, the ECS may support the regulation of gastric acid secretion, which could provide a pathway for managing conditions like GERD.

CB2 Receptors: Immune Support

While CB1 receptors handle the "wiring" of the gut, CB2 receptors function as immune system regulators. Found on T-cells, macrophages, and the epithelial lining, they serve as a component of the body’s defense against systemic inflammation.

Cytokine Modulation

In conditions like Crohn’s Disease, the immune system may overreact, releasing a cascade of pro-inflammatory cytokines. CB2 activation may help suppress this immune response—specifically inhibiting TNF-alpha. By cooling this immune activity at the molecular level, cannabinoids may help support the body’s path toward clinical remission.

Supporting the Gut Barrier

"Leaky gut" (intestinal permeability) occurs when the tight junction proteins that hold epithelial cells together fail, allowing substances to pass into the bloodstream. CB2 signaling may encourage the expression of these tight junction proteins, reinforcing the gut wall and supporting the barrier against systemic inflammation.

Beyond the Classics: GPR55 and TRPV1

To understand how cannabis affects gut health, one must consider receptors beyond the standard CB1 and CB2.

• GPR55 (The Third Receptor): This receptor regulates how intestinal cells migrate. Research suggests that when GPR55 is overactive, it may contribute to inflammatory bowel issues. CBD functions as a GPR55 antagonist, blocking this receptor to potentially help dial down inflammation.
• TRPV1 (The Vanilloid Receptor): Known for detecting heat and burning sensations, the TRPV1 receptor is often associated with the cramping experienced during inflammatory flares. Cannabinoids like CBD and CBG may desensitize these receptors, offering relief from the "burning" sensation of gut distress.

Maintaining "Endocannabinoid Tone"

The efficiency of the ECS depends on internal "Endocannabinoid Tone," which is determined by how quickly the body breaks down natural cannabinoids like Anandamide using enzymes like FAAH.

By inhibiting FAAH, CBD may prevent the rapid breakdown of these natural compounds. This allows them to circulate longer in the gut, providing sustained internal stability without relying on direct CB1 agonism.

Optimizing Phytocannabinoid Ratios for Gut Health

Effective gut intervention involves leveraging specific chemical profiles to target different receptors.

The 1:1 THC:CBD Ratio

This ratio is often utilized for acute flares. THC may manage motility and pain via CB1, while CBD balances potential THC-induced anxiety and targets the GPR55 inflammatory pathway.

The 2:1 CBD:CBG Ratio

CBG (Cannabigerol) is a CB2 agonist. This ratio is often used for managing chronic inflammation in Colitis or Crohn’s, as it focuses on calming the immune system and supporting the reduction of TNF-alpha production.

The Power of Beta-Caryophyllene

Beta-Caryophyllene is a dietary sesquiterpene that acts as a selective CB2 agonist. Because it binds directly to the CB2 receptors in the gut lining without needing to cross the blood-brain barrier, it acts as a localized, protective influence for the intestinal wall.

Summary of Receptor Activity

---

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

1. Sharkey KA, Wiley JW. (2016). The role of the endocannabinoid system in the brain-gut axis. Gastroenterology. 151(2):252-66. PubMed

2. Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed

3. Izzo AA, Sharkey KA. (2010). Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 126(1):21-38. PubMed

4. Bujak JK, Kosmala D, Szopa IM, Majchrzak K, Bednarczyk P. (2019). Inflammation, cancer and immunity—implication of TRPV1 channel. Front Oncol. 9:1087. PubMed

5. De Filippis D, Esposito G, Cirillo C, et al. (2011). Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 6(12):e28159. PubMed